Comparative Cost Analysis of Conventional Reconstructions and the First US Face Transplantation

  • James R. Gatherwright
  • Frank Papay
  • Risal Djohan
  • Elliott H. Rose
  • Lawrence J. Gottlieb
  • Maria Z. Siemionow


While the ethical and technical concerns regarding facial transplantation have been discussed throughout this book, there is a lack of information regarding its cost. Moreover, there is no information available in the literature on the financial implications of complete reconstructions in patients with severe craniomaxillofacial defects. We have had the unique opportunity to compare the cost of traditional reconstructive procedures and face transplantation in a single patient in our institution. In addition, we have also been able to compare the financial data of three other patients who underwent conventional reconstruction in other institutions: Mount Sinai Medical Center in New York and the University of Chicago. As the field of transplantation evolves, it will become increasingly important to disseminate this valuable information. Given the current economic climate in medicine, it will undoubtedly be a central issue to the face transplant debate. The following chapter illustrates these issues by comparing the cost of multistaged conventional reconstructive procedures in four patients with the cost of the first US face transplant.


Lower Eyelid Cartilage Graft Radial Forearm Flap Mount Sinai Medical Abdominal Flap 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Anti-thymocyte Immunoglobulin




Current Procedural Terminology


Composite Tissue Allotransplantation


End-Stage Renal Disease


Granulocyte Colony Stimulating Factor


Mycophenolate Mofetil


Pneumocystis Carinii Jerovici


Pneumococcal vaccine


Post-Traumatic Stress Disorder


  1. 1.
    Agich GJ, Siemionow M. Until they have faces: the ethics of facial allograft transplantation. J Med Ethics. 2005;31:707-709.PubMedCrossRefGoogle Scholar
  2. 2.
    Clark PA. Face transplantation: Part II-an ethical perspective. Med Sci Monit. 2005;11:RA41-RA47.PubMedGoogle Scholar
  3. 3.
    Alam DS, Papay F, Djohan R, et al. The technical and anatomical aspects of the World’s first near-total human face and maxilla transplant. Arch Facial Plast Surg. 2009;11:369-377.PubMedCrossRefGoogle Scholar
  4. 4.
    The International Registry on Hand Composite Tissue Transplantation Accessed 7/1/2010, Monza, Italy and Lyon, France, 2009.
  5. 5.
    Concannon MJ. Discussion: an economic analysis of hand transplantation in the United States. Plast Reconstr Surg. 2010;125:599-600.PubMedCrossRefGoogle Scholar
  6. 6.
    Siemionow M, Papay F, Alam D, et al. Near-total human face transplantation for a severely disfigured patient in the USA. Lancet. 2009;374:203-209.PubMedCrossRefGoogle Scholar
  7. 7.
    Siemionow MZ, Papay F, Djohan R, et al. First U.S. near-total human face transplantation: a paradigm shift for massive complex injuries. Plast Reconstr Surg. 2010;125:111-122.PubMedGoogle Scholar
  8. 8.
    Coffman KL, Gordon C, Siemionow M. Psychological outcomes with face transplantation: overview and case report. Curr Opin Organ Transplant. 2010;15:236-240.PubMedGoogle Scholar
  9. 9.
    Gordon CR, Siemionow M, Papay F, et al. The world’s experience with facial transplantation: what have we learned thus far? Ann Plast Surg. 2009;63:572-578.PubMedCrossRefGoogle Scholar
  10. 10.
    The 2010 Statistical Abstract; Births, deaths, marriages, and divorces: Life expectancy Washington, D.C.: United States Census Bureau, 2010:Table 103.Google Scholar
  11. 11.
    Siemionow M, Klimczak A. Tolerance and future directions for composite tissue allograft transplants: part II. Plast Reconstr Surg. 2009;123:7e-17e.PubMedCrossRefGoogle Scholar
  12. 12.
    Guo S, Han Y, Zhang X, et al. Human facial allotransplantation: a 2-year follow-up study. Lancet. 2008;372:631-638.PubMedCrossRefGoogle Scholar
  13. 13.
    Davies L. First hand and face transplant patient dies. Accessed 7/1/2010. London, U.K. 2009.
  14. 14.
    Macgregor FC. Facial disfigurement: problems and management of social interaction and implications for mental health. Aesthet Plast Surg. 1990;14:249-257.CrossRefGoogle Scholar
  15. 15.
    Maner JK, Kenrick DT, Becker DV, et al. Sexually selective cognition: beauty captures the mind of the beholder. J Pers Soc Psychol. 2003;85:1107-1120.PubMedCrossRefGoogle Scholar
  16. 16.
    Stevenage SV, Spreadbury JH. Haven’t we met before? The effect of facial familiarity on repetition priming. Br J Psychol. 2006;97(Pt 1):79-94.PubMedCrossRefGoogle Scholar
  17. 17.
    Stevenage SV, Lee EA, Donnelly N. The role of familiarity in a face classification task using thatcherized faces. Q J Exp Psychol A. 2005;58:1103-1118.PubMedGoogle Scholar
  18. 18.
    Rumsey N, Clarke A, White P, Wyn-Williams M, Garlick W. Altered body image: appearance-related concerns of people with visible disfigurement. J Adv Nurs. 2004;48:443-453.PubMedCrossRefGoogle Scholar
  19. 19.
    Levine E, Degutis L, Pruzinsky T, Shin J, Persing JA. Quality of life and facial trauma: psychological and body image effects. Ann Plast Surg. 2005;54:502-510.PubMedCrossRefGoogle Scholar
  20. 20.
    Robinson E, Rumsey N, Partridge J. An evaluation of the impact of social interaction skills training for facially disfigured people. Br J Plast Surg. 1996;49:281-289.PubMedCrossRefGoogle Scholar
  21. 21.
    Soni CV, Barker JH, Pushpakumar SB, et al. Psychosocial considerations in facial transplantation. Burns. 2010;36:959-964.PubMedCrossRefGoogle Scholar
  22. 22.
    Morris PJ, Bradley JA, Doyal L, et al. Facial transplantation: a working party report from the Royal College of Surgeons of England. Transplantation. 2004;77:330-338.PubMedCrossRefGoogle Scholar
  23. 23.
    Dubernard JM, Lengele B, Morelon E, et al. Outcomes 18 months after the first human partial face transplantation. N Engl J Med. 2007;357:2451-2460.PubMedCrossRefGoogle Scholar
  24. 24.
    Lantieri L, Meningaud JP, Grimbert P, et al. Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study. Lancet. 2008;372:639-645.PubMedCrossRefGoogle Scholar
  25. 25.
    Swanson E, Boyd JB, Manktelow RT. The radial forearm flap: reconstructive applications and donor-site defects in 35 consecutive patients. Plast Reconstr Surg. 1990;85:258-266.PubMedCrossRefGoogle Scholar
  26. 26.
    Bardsley AF, Soutar DS, Elliott D, Batchelor AG. Reducing morbidity in the radial forearm flap donor site. Plast Reconstr Surg. 1990;86:287-292. discussion 93-94.PubMedCrossRefGoogle Scholar
  27. 27.
    Anthony JP, Rawnsley JD, Benhaim P, Ritter EF, Sadowsky SH, Singer MI. Donor leg morbidity and function after fibula free flap mandible reconstruction. Plast Reconstr Surg. 1995;96:146-152.PubMedCrossRefGoogle Scholar
  28. 28.
    Zimmermann CE, Borner BI, Hasse A, Sieg P. Donor site morbidity after microvascular fibula transfer. Clin Oral Investig. 2001;5:214-219.PubMedCrossRefGoogle Scholar
  29. 29.
    Goodacre TE, Walker CJ, Jawad AS, Jackson AM, Brough MD. Donor site morbidity following osteocutaneous free fibula transfer. Br J Plast Surg. 1990;43:410-412.PubMedCrossRefGoogle Scholar
  30. 30.
    Boyd JB. Deep Circumflex Iliac Groin Flaps. New York: Churchill Livingstone; 1989.Google Scholar
  31. 31.
    Smith AA, Bowen CV, Rabczak T, Boyd JB. Donor site deficit of the osteocutaneous radial forearm flap. Ann Plast Surg. 1994;32:372-376.PubMedCrossRefGoogle Scholar
  32. 32.
    Richardson D, Fisher SE, Vaughan ED, Brown JS. Radial forearm flap donor-site complications and morbidity: a prospective study. Plast Reconstr Surg. 1997;99:109-115.PubMedCrossRefGoogle Scholar
  33. 33.
    Soutar DS, McGregor IA. The radial forearm flap in intraoral reconstruction: the experience of 60 consecutive cases. Plast Reconstr Surg. 1986;78:1-8.PubMedCrossRefGoogle Scholar
  34. 34.
    Youdas JW, Wood MB, Cahalan TD, Chao EY. A quantitative analysis of donor site morbidity after vascularized fibula transfer. J Orthop Res. 1988;6:621-629.PubMedCrossRefGoogle Scholar
  35. 35.
    Boyd JB, Rosen I, Rotstein L, et al. The iliac crest and the radial forearm flap in vascularized oromandibular reconstruction. Am J Surg. 1990;159:301-308.PubMedCrossRefGoogle Scholar
  36. 36.
    Swartz WM, Banis JC, Newton ED, Ramasastry SS, Jones NF, Acland R. The osteocutaneous scapular flap for mandibular and maxillary reconstruction. Plast Reconstr Surg. 1986;77:530-545.PubMedCrossRefGoogle Scholar
  37. 37.
    Gordon CR, Siemionow M, Zins J. Composite tissue allotransplantation: a proposed classification system based on relative complexity. Transplant Proc. 2009;41:481-484.PubMedCrossRefGoogle Scholar
  38. 38.
    Prihodova L, Nagyova I, Rosenberger J, Roland R, van Dijk JP, Groothoff JW. Impact of personality and psychological distress on health-related quality of life in kidney transplant recipients. Transpl Int. 2010;23:484-492.PubMedCrossRefGoogle Scholar
  39. 39.
    Smith GC, Trauer T, Kerr PG, Chadban SJ. Prospective quality-of-life monitoring of simultaneous pancreas and kidney transplant recipients using the 36-item short form health survey. Am J Kidney Dis. 2010;55:698-707.PubMedCrossRefGoogle Scholar
  40. 40.
    Knoll GA. Is kidney transplantation for everyone? The example of the older dialysis patient. Clin J Am Soc Nephrol. 2009;4:2040-2044.PubMedCrossRefGoogle Scholar
  41. 41.
    Buchanan P, Dzebisashvili N, Lentine KL, Axelrod DA, Schnitzler MA, Salvalaggio PR. Liver transplantation cost in the model for end-stage liver disease era: looking beyond the transplant admission. Liver Transplant. 2009;15:1270-1277.CrossRefGoogle Scholar
  42. 42.
    Simmons RG, Abress L, Anderson CR. Quality of life after kidney transplantation. A prospective, randomized comparison of cyclosporine and conventional immunosuppressive therapy. Transplantation. 1988;45:415-421.PubMedCrossRefGoogle Scholar
  43. 43.
    Helderman JH, Kang N, Legorreta AP, Chen JY. Healthcare costs in renal transplant recipients using branded versus generic cyclosporin. Appl Health Econ Health Policy. 2010;8:61-68.PubMedGoogle Scholar
  44. 44.
    Asgeirsdottir TL, Asmundsdottir G, Heimisdottir M, Jonsson E, Palsson R. Cost-effectiveness analysis of treatment for end-stage renal disease. Laeknabladid. 2009;95:747-753.PubMedGoogle Scholar
  45. 45.
    Kasiske BL, Cohen D, Lucey MR, Neylan JF. Payment for immunosuppression after organ transplantation. American Society of Transplantation. JAMA. 2000;283:2445-2450.PubMedCrossRefGoogle Scholar

Copyright information

© Springer London 2011

Authors and Affiliations

  • James R. Gatherwright
  • Frank Papay
  • Risal Djohan
  • Elliott H. Rose
  • Lawrence J. Gottlieb
  • Maria Z. Siemionow
    • 1
  1. 1.Department of Plastic SurgeryCleveland ClinicClevelandUSA

Personalised recommendations